4.5 Review

microRNAs in colon cancer: A roadmap for discovery

期刊

FEBS LETTERS
卷 586, 期 19, 页码 3000-3007

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.febslet.2012.07.048

关键词

Omic; microRNA; Colon cancer; Personalized medicine

资金

  1. Foundation Fournier-Majoie
  2. King Baudouin Foundation, Belgium
  3. William M. Keck Foundation grant

向作者/读者索取更多资源

Cancer omics data are exponentially created and associated with clinical variables, and important findings can be extracted based on bioinformatics approaches which can then be experimentally validated. Many of these findings are related to a specific class of non-coding RNA molecules called microRNAs (miRNAs) (post-transcriptional regulators of mRNA expression). The related research field is quite heterogeneous and bioinformaticians, clinicians, statisticians and biologists, as well as data miners and engineers collaborate to cure stored data and on new impulses coming from the output of the latest Next Generation Sequencing technologies. Here we review the main research findings on miRNA of the first 10 years in colon cancer research with an emphasis on possible uses in clinical practice. This review intends to provide a road map in the jungle of publications of miRNA in colorectal cancer, focusing on data availability and new ways to generate biologically relevant information out of these huge amounts of data. (C) 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据